Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:985-990

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nagano, M.
Right arrow Articles by Matsuzawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nagano, M.
Right arrow Articles by Matsuzawa, Y.
Related Collections
Right arrow Pathophysiology
Right arrow Gene regulation
Right arrow Lipid and lipoprotein metabolism
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:985.)
© 2001 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Point Mutation (-69 G->A) in the Promoter Region of Cholesteryl Ester Transfer Protein Gene in Japanese Hyperalphalipoproteinemic Subjects

Makoto Nagano; Shizuya Yamashita; Ken-ichi Hirano; Takeshi Kujiraoka; Mayumi Ito; Yukiko Sagehashi; Hiroaki Hattori; Norimichi Nakajima; Takao Maruyama; Naohiko Sakai; Tohru Egashira; Yuji Matsuzawa

From the Research Department, R&D Center, BML, Saitama (M.N., T.K., M.I., Y.S., H.H., T.E.); the Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka (S.Y., K.H., T.M., N.S.); and Nakajima Clinic, Akita (N.N.), Japan.

Correspondence to Shizuya Yamashita, MD, PhD, Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan. E-mail shizu{at}imed2.med.osaka-u.ac.jp

Abstract—Cholesteryl ester transfer protein (CETP) transfers cholesteryl ester (CE) from HDL to apolipoprotein (apo) B–containing lipoproteins and plays a crucial role in reverse cholesterol transport, which is a major protective system against atherosclerosis. Genetic CETP deficiency is the most common cause of a marked hyperalphalipoproteinemia (HALP) in the Japanese, and various mutations have been identified in the coding region as well as in the exon/intron boundaries in the CETP gene. In the present study, we identified a novel mutation in the promoter region of the CETP gene. This mutation was a G-to-A substitution at the -69 nucleotide of the promoter region (-69 G->A), corresponding to the second nucleotide of the PEA3/ETS binding site (CGGAA) located upstream of the putative TATA box. Four (2.0%) of 196 unrelated subjects with a marked HALP (HDL cholesterol >=2.59 mmol/L=100 mg/dL) were revealed to be heterozygous for the -69 G->A mutation, and the allelic frequency of the mutant was 0.0102 in the subjects with a marked HALP. The subjects with the -69 G->A mutation had low plasma CETP levels. Reporter gene assay showed that this mutation markedly reduced the transcriptional activities in HepG2 cells (8% of wild type). These results suggested that this mutation would be dominant negative. In conclusion, a novel -69 G->A mutation in the CETP gene causes the decreased transcriptional activity leading to HALP.


Key Words: cholesteryl ester transfer protein deficiency • hyperalphalipoproteinemia • mutation • promoter • PEA3/ETS binding site




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. M. Boekholdt and J. F. Thompson
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
J. Lipid Res., July 1, 2003; 44(6): 1080 - 1093.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
T. Oka, S. Yamashita, T. Kujiraoka, M. Ito, M. Nagano, Y. Sagehashi, T. Egashira, M. N. Nanjee, K.-i. Hirano, N. E. Miller, et al.
Distribution of human plasma PLTP mass and activity in hypo- and hyperalphalipoproteinemia
J. Lipid Res., August 1, 2002; 43(8): 1236 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Nagano, S. Yamashita, K.-i. Hirano, M. Ito, T. Maruyama, M. Ishihara, Y. Sagehashi, T. Oka, T. Kujiraoka, H. Hattori, et al.
Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader (R) assay
J. Lipid Res., July 1, 2002; 43(7): 1011 - 1018.
[Abstract] [Full Text] [PDF]